Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
UGT3A1 (human)
p Phosphorylation
a Acetylation
m Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
u Ubiquitination
s Sumoylation
n Neddylation
g O-GlcNAc
h Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage

Overview
UGT3A1 UDP-glucuronosyltransferases catalyze phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase water solubility and enhance excretion. They are of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Belongs to the UDP-glycosyltransferase family. Note: This description may include information from UniProtKB.
Protein type: Transferase; EC 2.4.1.17; Membrane protein, integral; EC 2.4.1.45
Cellular Component: integral to membrane
Molecular Function: glucuronosyltransferase activity
Reference #:  Q6NUS8 (UniProtKB)
Alt. Names/Synonyms: FLJ26528; FLJ34658; UD3A1; UDP glycosyltransferase 3 family, polypeptide A1; UDP-glucuronosyltransferase 3A1; UDPGT 3A1; UGT3A1
Gene Symbols: UGT3A1
Molecular weight: 59,151 Da
Basal Isoelectric point: 8.2  Predict pI for various phosphorylation states
Select Structure to View Below

UGT3A1
Protein Structure Not Found.


STRING  |  Scansite  |  Phospho.ELM  |  NetworKIN  |  Pfam  |  ENZYME  |  InnateDB  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


  MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


        human

 
0 1 E69 FLIPDIKEEEKSYQV
0 1 - under review  
0 3 Y123-p IFGTQCSyLLSRkDI
0 1 K128-a CSyLLSRkDIMDSLk
0 1 K128 CSyLLSRKDIMDSLk
0 1 K135-a kDIMDSLkNENYDLV
0 1 S211-p FLMFFSFsRSQWDMQ
0 1 S374-p VTHGGQNsVMEAIRH
0 1 - under review  
  mouse

 
K68-u GDIPDFRkENSSYQV
K86-u RLPEDQQkTFENRWH
H122 YFADLCSHLLSRkDI
K127 CSHLLSRKDIMELLQ
K127-u CSHLLSRkDIMELLQ
Q134 kDIMELLQKENFDLV
T211 ILMFFHFTKKRRDIF
S374 VTHGGMNSVMEAVHH
K441-u KTAAMASkVIRQSHP
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.